#Blood Gas And Electrolyte Analyzers Industry

[tamanna31]

Industry Outlook of Blood Gas And Electrolyte Analyzer Market 2024 Trends to 2030

Blood Gas And Electrolyte Analyzer Industry Overview

The global blood gas and electrolyte analyzer market size was estimated at USD 2.76 billion in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030. The market's growth is attributed to the growing prevalence of chronic diseases, rising geriatric population, and increasing regulatory support and funding for developing novel blood gas and electrolyte analyzers. Chronic diseases such as diabetes, cardiovascular diseases, and chronic respiratory conditions are becoming common due to various factors, including lifestyle changes and urbanization. These conditions require continuous monitoring and management.

Chronic diseases lead to complications that require blood gas and electrolyte analysis. For instance, diabetes can lead to diabetic ketoacidosis, a condition that necessitates the monitoring of blood pH and electrolyte levels. Similarly, cardiovascular diseases can result in heart failure, demanding regular checks of blood oxygen levels and electrolyte balance. As the prevalence of these diseases rises, the demand for blood gas and electrolyte analyzers is growing.

The growing geriatric population worldwide significantly drives the market. Aging leads to an increase in age-related diseases and conditions that require close monitoring & management. These conditions necessitate blood gas and electrolyte analyzers, which measure various parameters such as pH, gases (oxygen & carbon dioxide), and electrolytes in the blood. This equipment is crucial in diagnosing and monitoring patients in critical care, respiratory care, and for those undergoing surgery. According to the Population Reference Bureau, the number of individuals in the U.S. aged 65 years and above is projected to increase from 58 million in 2022 to 82 million by 2050. This rising aging population is anticipated to bring about challenges and opportunities in the country with the rising adoption of blood gas and electrolyte analyzers.

Gather more insights about the market drivers, restrains and growth of the Blood Gas And Electrolyte Analyzer Market

Regulatory support and funding are crucial factors driving the market. These analyzers are essential for critical care, emergency departments, and clinical laboratories, providing vital information about patients' respiratory & metabolic status. Governments across various regions have been focusing on improving healthcare infrastructure and quality. Regulatory bodies have implemented stringent guidelines and standards for medical devices, ensuring the reliability, accuracy, and safety of blood gas & electrolyte analyzers. This regulatory environment helps build trust among healthcare providers and patients, promoting the adoption of these devices.

Furthermore, with the expansion of healthcare facilities, mainly in rural and remote areas, there is a growing demand for advanced medical equipment. New hospitals and clinics need the latest diagnostic technologies to provide high-quality care, driving the market demand. Regulatory bodies and governments conduct awareness programs and provide training for healthcare professionals on the latest medical technologies. This helps increase the adoption of new devices as healthcare providers become more knowledgeable about the benefits and usage of blood gas & electrolyte analyzers.

However, the high cost of advanced analyzers is one of the key factors restraining the market's growth. These advanced analyzers integrate advanced technology and features that offer precise & rapid results, which are crucial for critical care. Moreover, their high cost makes them less accessible to many healthcare facilities, especially in the developing countries of Southeast Asia, where budget constraints are a significant concern. In addition to the initial purchase price, advanced analyzers require ongoing expenditures for consumables such as reagents & cartridges and regular maintenance. These recurring costs can add up, making the overall cost of ownership high. Healthcare providers may be hesitant to invest in such equipment due to the long-term financial commitment required.

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global surgical drills market size was estimated at USD 1.27 billion in 2023 and is projected to grow at a CAGR of 5.5% from 2024 to 2030. 

The global oral appliances market size was estimated at USD 908.7 million in 2023 and is expected to grow at a CAGR of 5.72% from 2024 to 2030.

Key Blood Gas And Electrolyte Analyzer Company Insights

Some leading players operating in the market include Abbott, Radiometer Medical ApS, Werfen, and Meizhou Cornley High-Tech Co., Ltd. Key players adopt various operating strategies to maintain their market positions. One key strategy is product innovation and differentiation. Moreover, these players emphasize innovation to derive innovation and bring new solutions to the market. The rising demand for technologically advanced products drives the competition among key players.

Scitek Global Co., Ltd., EDAN Instruments, Inc., and Erba Mannheim are some of the emerging market participants. Emerging players often develop novel products with unique features to differentiate themselves. The companies are focusing on introducing tools that can help in blood gas and electrolyte analysis to meet consumer demand, which is expected to drive competition among emerging players.

Key Blood Gas And Electrolyte Analyzer Companies:

The following are the leading companies in the blood gas and electrolyte analyzer market. These companies collectively hold the largest market share and dictate industry trends.

Abbott

Meizhou Cornley High-Tech Co., Ltd.

Radiometer Medical ApS

EDAN Instruments, Inc.

Erba Mannheim

F. Hoffmann-La Roche Ltd

Fortress Diagnostics

Werfen

LifeHealth

Medica Corporation

OPTI Medical Systems, Inc.

Sensa Core

Siemens Healthineers AG

Recent Developments

In May 2024, Radiometer partnered with Etiometry to enhance workflow and clinical decision-making in hospital and healthcare settings. This partnership involves the integration of Radiometer’s acute care diagnostics with the Etiometry platform to improve the critical care settings for blood gas analysis.

In June 2023, B&E BIO-TECHNOLOGY CO., LTD. announced the launch of an i-Check handheld blood gas electrolyte to help enhance and advance point-of-care testing capabilities.

In September 2021, Sensa Core Medical Instrumentation announced the launch of ST-200CC Blood Gas Analyzers, its flagship blood gas analyzer used in clinics, hospitals, and diagnostic centers through its widespread network in India.

Order a free sample PDF of the Blood Gas And Electrolyte Analyzer Market Study, published by Grand View Research.

[trendtrackershq]

𝑩𝒍𝒐𝒐𝒅 𝑮𝒂𝒔 𝒂𝒏𝒅 𝑬𝒍𝒆𝒄𝒕𝒓𝒐𝒍𝒚𝒕𝒆 𝑨𝒏𝒂𝒍𝒚𝒛𝒆𝒓 𝑴𝒂𝒓𝒌𝒆𝒕 𝑮𝒖𝒊𝒅𝒆

𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝒂 𝑭𝑹𝑬𝑬 𝑺𝒂𝒎𝒑𝒍𝒆: https://www.nextmsc.com/blood-gas-and-electrolyte-analyzer-market/request-sample

The 𝑩𝒍𝒐𝒐𝒅 𝑮𝒂𝒔 𝒂𝒏𝒅 𝑬𝒍𝒆𝒄𝒕𝒓𝒐𝒍𝒚𝒕𝒆 𝑨𝒏𝒂𝒍𝒚𝒛𝒆𝒓 𝑴𝒂𝒓𝒌𝒆𝒕 is witnessing significant growth, driven by the rising prevalence of chronic diseases, advancements in healthcare technology, and increasing demand for point-of-care testing.

𝑲𝒆𝒚 𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔:

𝑴𝒂𝒓𝒌𝒆𝒕 𝑮𝒓𝒐𝒘𝒕𝒉: The global Blood Gas and Electrolyte Analyzer Market size is projected to reach $3.5 billion by 2030, with a CAGR of 6.9% from 2024 to 2030.

𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒊𝒄𝒂𝒍 𝑨𝒅𝒗𝒂𝒏𝒄𝒆𝒎𝒆𝒏𝒕𝒔: Innovations such as portable analyzers and integrated systems are revolutionizing patient care by providing accurate and rapid results.

𝑮𝒍𝒐𝒃𝒂𝒍 𝑹𝒆𝒂𝒄𝒉: North America leads the market share, followed by Europe and the Asia-Pacific region, reflecting robust healthcare infrastructure and increased investment in medical devices.

𝑨𝒑𝒑𝒍𝒊𝒄𝒂𝒕𝒊𝒐𝒏 𝑺𝒑𝒆𝒄𝒕𝒓𝒖𝒎: These analyzers are crucial in various settings, including ICU, emergency departments, and ambulatory care, enhancing patient outcomes and operational efficiency.

𝑶𝒑𝒑𝒐𝒓𝒕𝒖𝒏𝒊𝒕𝒊𝒆𝒔: The expanding application of these analyzers in home care settings and emerging markets presents substantial growth potential.

𝑲𝒆𝒚 𝑷𝒍𝒂𝒚𝒆𝒓𝒔: Various market players operating in the blood gas and electrolyte analyzer industry include Abbott Laboratories, Siemens Healthineers, Radiometer Medical, Roche Diagnostics, Nova Biomedical Corporation, Erba Mannheim, Techno Medica, Horiba Medical, Edan Instruments, OPTI Medical Systems, Medica Corporation, Werfen, i-SENS, Senso Care, Perlong Medical Equipment Co., Ltd, and others.

𝑨𝒄𝒄𝒆𝒔𝒔 𝑭𝒖𝒍𝒍 𝑹𝒆𝒑𝒐𝒓𝒕: https://www.nextmsc.com/report/blood-gas-and-electrolyte-analyzer-market

Let's connect and discuss how these trends could impact our industry and explore collaborative opportunities in this dynamic market!

[marketsizereports]

Key Players in the POC Analyzers Market: A Company Spotlight

The Point-of-Care (POC) Analyzers Market is vibrant, with several key players contributing to the development and advancement of portable diagnostic solutions.

Buy the Full Report for Detailed Segments Insights into the POC Analyzers Market, Download a Free Report Sample

This company spotlight highlights some of the prominent players in this dynamic market:

Abbott Laboratories:

Abbott is a global healthcare company with a diverse portfolio, including a range of POC analyzers. Their offerings cover areas such as blood glucose monitoring, cardiac markers, infectious diseases, and molecular diagnostics. Abbott aims to provide rapid and accurate diagnostic solutions to improve patient outcomes.

Roche Diagnostics:

Roche Diagnostics, a division of the Swiss multinational Roche Group, is a leading player in the POC analyzers market. Their portfolio includes devices for testing blood gases, electrolytes, cardiac markers, and coagulation parameters. Roche focuses on delivering reliable and efficient solutions for decentralized testing.

Siemens Healthineers:

Siemens Healthineers is a global medical technology company known for its innovative diagnostic solutions. In the POC analyzers market, Siemens offers devices for testing blood gases, cardiac markers, and infectious diseases. Their emphasis on connectivity and data management contributes to streamlined healthcare workflows.

Danaher Corporation (Beckman Coulter):

Beckman Coulter, a subsidiary of Danaher Corporation, is a key player in the POC diagnostics space. Their POC analyzers cover a wide range of parameters, including chemistry, hematology, and immunoassays. Beckman Coulter focuses on delivering solutions that enhance clinical decision-making.

Sysmex Corporation:

Sysmex, a Japanese multinational corporation, is a prominent player in the global in-vitro diagnostics market. In the POC analyzers segment, Sysmex offers solutions for hematology testing, contributing to rapid and accurate blood analysis in various healthcare settings.

Quidel Corporation:

Quidel Corporation specializes in diagnostic testing solutions, including a range of POC analyzers. Their portfolio covers tests for infectious diseases, cardiac markers, and women's health. Quidel aims to provide rapid and accurate results to facilitate timely clinical decisions.

Nova Biomedical:

Nova Biomedical is a U.S.-based company known for its commitment to POC testing solutions. They offer analyzers for blood gas, electrolyte, and critical care testing. Nova Biomedical focuses on delivering high-performance POC analyzers for use in various healthcare settings.

Alere Inc. (Now part of Abbott):

Alere, acquired by Abbott, was a major player in POC diagnostics before the acquisition. Their portfolio included rapid tests and analyzers for infectious diseases, cardiac markers, and women's health. The integration with Abbott has strengthened the company's position in the POC market.

BioMérieux SA:

BioMérieux, a French multinational company, is a key player in the field of in-vitro diagnostics. In the POC analyzers market, BioMérieux focuses on solutions for infectious disease testing, including molecular diagnostics and immunoassays.

PTS Diagnostics:

PTS Diagnostics specializes in developing and manufacturing POC diagnostic products. Their portfolio includes analyzers for lipid panels, diabetes management, and cardiovascular risk assessment. PTS Diagnostics aims to provide cost-effective and user-friendly solutions for decentralized testing.

It's important to note that the POC analyzers market is dynamic, and the landscape may have evolved since my last knowledge update. Additionally, new players may have entered the market, and strategic partnerships or acquisitions may have occurred. For the latest information, it's advisable to refer to recent reports, company announcements, and industry publications.

[techninja]

Advancements in Healthcare Analytical Instrumentation: A Key Driver for Improved Patient Outcomes

Introduction

The healthcare analytical instrumentation and systems market is at the forefront of advancing medical diagnostics and research. These innovative technologies play a pivotal role in improving patient care, drug development, and our overall understanding of human health. In this article, we will explore the key components, trends, and growth drivers of this dynamic market.

Components of Healthcare Analytical Instrumentation and Systems

1. Spectroscopy Systems: Spectroscopy is a powerful analytical technique that uses the interaction between light and matter to study the composition and properties of substances. It is widely used in medical diagnostics, pharmaceuticals, and environmental monitoring. Spectroscopy systems, including mass spectrometers and NMR machines, are essential for identifying and quantifying various molecules within biological samples.

2. Chromatography Instruments: Chromatography is another critical technique that separates and analyzes complex mixtures. High-performance liquid chromatography (HPLC) and gas chromatography (GC) are commonly used in healthcare for drug testing, clinical research, and quality control of pharmaceuticals.

3. Clinical Chemistry Analyzers: These instruments are indispensable in clinical laboratories for analyzing blood, urine, and other bodily fluids. They help diagnose diseases and monitor patients' health by measuring biomarkers, electrolytes, and various metabolites.

4. Molecular Diagnostics Instruments: Molecular diagnostics has witnessed remarkable growth in recent years. Instruments like PCR machines and DNA sequencers are pivotal for identifying genetic mutations, pathogens, and tracking the progression of diseases, including cancer.

5. Microscopy Systems: Microscopes have come a long way since their invention. Advanced microscopy systems enable researchers to visualize cellular structures, tissues, and even individual molecules. This aids in both diagnostics and understanding the intricate workings of the human body.

Key Trends and Growth Drivers

1. Rapid Technological Advancements: Continuous innovations in healthcare analytical instrumentation and systems have revolutionized medical research and diagnostics. Miniaturization, automation, and integration with data analytics and artificial intelligence are shaping the industry.

2. Personalized Medicine: The shift toward personalized medicine has fueled the demand for more precise and efficient analytical instruments. These tools help tailor treatments to individual patients, considering their unique genetic makeup and health conditions.

3. Increasing Chronic Diseases: The rising prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and cancer, necessitates advanced diagnostic tools for early detection and effective management.

4. Pharmaceutical Research: The pharmaceutical industry relies on analytical instrumentation for drug discovery, development, and quality control. As new drugs are developed, the need for advanced analytical instruments grows.

5. Growing Focus on Preventive Healthcare: Preventive healthcare measures, including routine screenings and early disease detection, are on the rise. This trend underscores the significance of accurate and efficient analytical systems.

Market Challenges

While the healthcare analytical instrumentation and systems market is poised for significant growth, it faces several challenges:

1. Cost Constraints: High initial costs and maintenance expenses associated with advanced instrumentation can be a barrier, particularly in resource-constrained healthcare settings.

2. Regulatory Compliance: Stringent regulatory requirements in healthcare necessitate that instrumentation and systems meet specific standards, which can increase the time and cost of product development.

3. Skilled Workforce: The operation and maintenance of these sophisticated systems require a skilled workforce, creating a need for specialized training.

Conclusion

The healthcare analytical instrumentation and systems market is essential for the advancement of medical diagnostics, treatment, and research. With rapid technological advancements, a growing focus on personalized medicine, and the rise of preventive healthcare, this industry is poised for remarkable growth. Overcoming challenges such as cost constraints and regulatory compliance will be essential to realizing the full potential of these cutting-edge technologies in improving healthcare outcomes and patient well-being. As the market continues to evolve, we can expect even more groundbreaking innovations in the field of healthcare analytical instrumentation and systems.

Few other promising reports in Medical Device Industry

3D Printing in Healthcare Market

Extracellular Matrix Market

Butterfly Needles Market

Colon Hydrotherapy Machine Market

[healthpulsetoday]

The Essential Components of Value-Based Healthcare Delivery

The healthcare industry is rapidly evolving, and the traditional fee-for-service model is slowly being replaced by value-based healthcare. Value-based healthcare is an approach that prioritizes patient outcomes and quality of care over the volume of services provided. The focus is on delivering the highest quality of care to patients while reducing costs and improving efficiencies.

Why is Value-Based Healthcare Important?

Value-based healthcare is essential because it creates a more patient-centric approach to healthcare delivery. Patients receive better care, and providers are incentivized to improve the quality of care they provide. In a fee-for-service model, providers are paid based on the number of services they provide, regardless of the outcome. This can lead to unnecessary tests and procedures, driving up the cost of healthcare.

Value-based healthcare encourages providers to focus on patient outcomes, which leads to better care and a reduction in overall healthcare costs. This approach is particularly important in a healthcare system that is struggling to control costs while providing quality care to an aging population.

What Are the Benefits of Value-Based Healthcare Delivery?

Value-based healthcare delivery provides many benefits to both patients and providers. Patients receive better care, which leads to better health outcomes, and providers achieve efficiencies and increased patient satisfaction.

Providers achieve efficiencies and increased patient satisfaction

Value-based healthcare incentivizes providers to reduce the number of unnecessary tests and procedures, which can lead to better patient outcomes and increased patient satisfaction. Providers can also leverage technologies such as artificial intelligence (AI) and telehealth to provide more efficient care. AI can help providers identify patients who are at risk of developing chronic conditions and provide proactive care. Telehealth can also improve access to care, particularly for patients in rural or remote areas.

Future Impact of Value-Based Healthcare

The future impact of value-based healthcare is significant. The healthcare industry is rapidly evolving, and value-based healthcare is the future of healthcare delivery. The adoption of value-based healthcare will require a significant investment in technology and infrastructure. Healthcare providers will need to adopt technologies such as AI and telehealth to provide efficient and effective care.

Value-based healthcare will also require changes to the way healthcare is delivered. Providers will need to work together to provide coordinated care and focus on patient outcomes. This approach will require a significant shift in the way providers are incentivized and reimbursed.

In conclusion, value-based healthcare is an essential approach to healthcare delivery that prioritizes patient outcomes and quality of care over the volume of services provided. This approach provides many benefits to patients and providers, including increased efficiencies and improved patient satisfaction. As the healthcare industry continues to evolve, the adoption of value-based healthcare will become increasingly important. Providers will need to invest in technology and infrastructure and work together to provide coordinated care that delivers the best outcomes for patients.

Trending Report

Concussions Market Size | Pruritus Market | Angioedema Market | Blood Gas And Electrolyte Analyzers Market | Human Papilomavirus Market | Neurovascular Devices Market | Pain Management Devices Market | Pressure Ulcers Market Size | Acute Coronary Syndrome Market | Apheresis Market | Arteriotomy Closure Devices Market | Automated External Defibrillators Market | Xerostomia Market | Choroidal Neovascularization Market | Hyperhidrosis Market | Alopecia Market | Contraceptive Devices Market | Ventilator Market | Alopecia Aerata Market | Osteoarthritis Market | Neurostimulation Devices Market | Global Electrophysiology Devices Market | Astigmatism Market | Graves Orbitopathy Market | HPV-Induced Cancers Market | Hypothalamic Obesity Market | Italy healthcare outlook report

Consulting Services:

Biotech Consulting | Business Consulting Services | Consulting Services | Healthcare Business Development | Healthcare Consulting Services | Healthcare Strategy Consulting | Life Science Consulting | Life Science Consulting Firms

[neha24blog]

Blood Gas And Electrolyte Analyzers Market Is Expected To Reach USD 653.5 Million By 2022: Grand View Research Inc.

San Francisco, 24 March 2020 : The Report Blood Gas and Electrolyte Analyzers Market Size & Trends Analysis Report, By Product (Benchtop Blood Gas & Electrolyte Analyzers, Portable Blood Gas & Electrolyte Analyzers), By End-use, And Segment Forecasts, 2012 – 2022

The global blood gas and electrolyte market is expected to reach USD 653.5 million by 2022, according to a new study by Grand View…

[healthcare-stuff-blog]

Key factors attributing to the growth of the blood gas and electrolyte analyzers market

Global blood gas and electrolyte market is expected to reach USD 653.5 million by 2022, according to a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care.

Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected to boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.

Further key findings from the study suggest:

Portable analyzers dominated the market with a share of over 60.0% in 2014 and are also expected to witness lucrative growth over the forecast period. Growing demand for automated, self-monitoring, portable devices, shorter analysis time, and quick accurate results are key factors boosting the growth of this segment.

Combined blood gas and electrolyte analyzers are expected to rapidly gain market share over the forecast period. Rising need for analyzers, which can analyze blood and electrolyte samples together are swiftly gaining popularity among users.

North America accounted for more than 40% of the blood gas and electrolyte analyzers market in 2014. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected to drive regional market growth.

Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.

Key players of the blood gas and electrolyte analyzers market include Siemens, Medica, Roche, Nova Stat, Bayer, Radiometer Medical, Convergent technologies, Dalko Diagnostics, Afford Medical Technologies, and Accurex Biomedical Pvt. Ltd.

To request a sample copy or view summary of this report, click the link below: http://www.grandviewresearch.com/industry-analysis/blood-gas-and-electrolyte-analyzers

[researchinhealthcare]

POC Blood Gas and Electrolyte Devices Market to Touch till 2023 | Global Industry Analysis

POC Blood Gas and Electrolyte Devices Market Highlights :

Point of care blood gas and electrolyte analyzers is the new technology, which helps in reducing therapeutic turnaround time, enhancing patient satisfaction, accuracy, and help to improve hospital operations. Rising prevalence of chronic diseases and cancer across the globe, increasing the treatment of NICUs, ICUs, Cardiovascular Operating Room (CVOR), and emergency department, which drives the global point of care blood gas and electrolyte devices market growth.

In 2017, due to changes in the regulatory policies of the U.S., R&D investment is affected to some extent. In 2016, R&D spending of the US was 527.5 billion, which grew by 1.6% in 2017. Currently, the major shares of the global market are dominated by few leading players, and they can fluctuate the costs of the products. In developing regions such as Asia Pacific the suppliers are trying to provide their products at affordable price.

The global point of care blood gas and electrolyte devices market is expected to grow at a CAGR of 7.8% during the forecast period 2017-2023.

POC Blood Gas and Electrolyte Devices Market Segmentation :

The global point of care blood gas and electrolyte gas devices market has been segmented on the basis of types and end users.

On the basis of the types, the market is segmented into consumables and Instruments. The instrument type is sub-segmented into benchtop and portable devices. The consumable devices are further segmented into reagents, cartridges, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, home care, research institutions, and others.

Free Sample Report Click @ https://www.marketresearchfuture.com/sample_request/5085

POC Blood Gas and Electrolyte Devices Market Regional Analysis :

The Americas dominate the global market owing to a huge population with chronic diseases such as diabetes, kidney, and liver disease, increasing government support for research & development, and high health care expenditure. According to the WHO, in 2014, 9.7% of the total America population is having diabetes. Thus, increasing prevalence of diabetes has boosted the market growth. Additionally, changing lifestyle and the presence of major players in the market have fuelled the growth of the market.

Europe is the second largest point of care devices market across the globe, which is followed by Asia Pacific. Asia Pacific is the fastest growing market and majorly driven by India and China owing to a huge number patients with chronic diseases and rapidly growing economy.

According to the WHO, 60% of the global diabetic population lives in Asia Pacific region. The healthcare expenditure of Asia Pacific has increased over the last few years, which has contributed to the growth of the market.

The Middle East and Africa region account for the least share of the global market. Whereas, Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition of the region.

POC Blood Gas and Electrolyte Devices Market Key Players :

Some of the major players in this market: Siemens, Abbott, F. Hoffman-La Roche Ltd., Radiometer, Nova medical, Edan Instruments Inc., and Instrumentation Laboratory

Access Report Details @ https://www.marketresearchfuture.com/reports/poc-blood-gas-and-electrolyte-market-5085

[themarketresearchtrends-blog]

Blood Gas And Electrolyte Analyzers Market Outlook, Volume & Revenue by 2022

6 Nov 2018 - The Global Blood Gas And Electrolyte Analyzers Market was valued at USD 495.8 million in 2016 and, is expected to grow at a CAGR of 4.7% over the forecast period. An increase in demand for blood gas testing, growing incidence among the patients in emergency departments and critical care, increasing healthcare expenditure, increase in the change of focus towards point-of-care testing and introduction of new expertise are some of the most affecting drivers of this market.

Increase in the base population will also contribute towards the growth of the market in the coming years by resulting in high occurrence rates of diseases which include cancer, respiratory disorders, diabetes, and heart-related diseases. Furthermore, the appearance of multi-parameter monitoring device which helps in increasing test menus and rise in requirement for miniaturized devices which is expected to improve market growth over the coming period. For example, according to the WHO, the global geriatric population of 65 years and above will help to rise from 7% in 2000 to 16% in 2050. For cancer and other chronic diseases, aging is one of the risk factors and therefore, the global aging population will help to increase its market growth.

Product Insights

Portable analyzers and benchtop are key product categorization of the electrolyte and blood gas segment. Benchtop analyzers with a display (LCD) are larger, with a keypad to enter information and also contains a slot for placing in a sample tube or test strip, while portable analyzers are movable thus facilitating bedside examination. In 2016, the portable analyzers market held the major share at over 62%. Portable analyzers have many advantages which includes automation of tasks, portability and ease-of-use, decreased manual errors, self-assessing ability and low maintenance which are estimated to act as key drivers contributing to increase in the growth of the market share.

Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/blood-gas-electrolyte-analyzers-market/request-sample

Application Insights

In 2016, combined analyzers conquered the overall market due to the occurrence of broad product portfolio with large test volumes. The combined analyzer market is anticipated to witness an increase in growth as a result of increasing need for analyzers which need less maintenance, further facilitating the test results for electrolyte and blood count from samples such as whole dialysate, urine, blood, serum, and plasma.

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/blood-gas-electrolyte-analyzers-market

End-use Insights

The market is divided on the basis of end-use into central laboratories and point-of-care. The point-of-care division is identified to be the best growing segment in the coming years. The key contributing factor is the continuous technological improvements, thus attracting end-users to move focus towards point-of-care analysers.

Special importance is given to cardiothoracic surgical departments, followed by emergency transport systems, and critical care departments as designated by a large volume of systems. The increase in demand for point-of-care blood gas and electrolyte analysers is expected to growth over the forecast period. These devices facilitate automated sample handling which helps to trim down the associated errors along with providing user variability. The aforementioned factors are expected to help these devices to achieve high preference matrix among the consumers.

Regional Insight

In 2016, North America held substantial amount of share of this market. Some of the key factors which help in boosting the regional market growth includes the increase in number of patients treated in hospitals annually, particularly in the intensive care units and emergency departments coupled with the presence of supportive healthcare infrastructure.

Whereas, Asia-Pacific is expected to provide future growth opportunities because of presence of large number of manufacturers. In India and China, increasing disposable income levels along with the existence of high unmet patient needs are some factors for growth rate of this segment. Additionally, in the developing countries, the presence of favorable government policies and programs are expected to boost this market. For example, in MEA the favorable government initiatives such as the UNFPA initiated by the Country Programme Action Plan (CPAP) for prevention of diseases is expected to improve the healthcare services which further results into providing new opportunities for market growth.

Competitive Insights

Key local players of this market include, Abbott, Siemens, Bayer, Roche, OPTI medical systems Inc., Samsung Medison, Medica, Nova Stat, Erba, Radiometer Medical, Alere Medical, Edan Instruments, Afford Medical, Dalko Diagnostics, Convergent Technologies and Accurex Biomedical Pvt. Ltd.

Introducing strategic collaborations, entering into acquisitions & mergers and increasing product portfolio are some key sustainability strategies implemented by these market players. For example, in September 2012, Maxmat S.A was acquired by Erba Mannheim, which is a French company in service of manufacturing medical laboratory devices. This helped the parent company, minimize product development period and provide the alteration in the requirements of the consumers.

See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare

[markettrend24]

Blood Gas and Electrolyte Analyzers Market Growth, Overview with Detailed Analysis 2022-2028

Blood Gas and Electrolyte Analyzers Market Growth, Overview with Detailed Analysis 2022-2028

This report studies the Blood Gas and Electrolyte Analyzers Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Blood Gas and Electrolyte Analyzers Market analysis segmented by companies, region, type…

[nikhilghodse20051994]

Companion Animal Diagnostics Market Forecast, Trend, Analysis 2028

According to the latest study on “Companion Animal Diagnostics Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Technology, Application, Animal Type, and End User", the global companion animal diagnostics market was valued at US$ 2,031.62 million in 2019 and is projected to reach US$ 2,684.86 million by 2027; it is expected to grow at a CAGR of 4.1% during 2020–2027. The report highlights trends prevailing in the global companion animal diagnostics market and the factors driving market along with those that act as hindrances.

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis –

The companion animal diagnostics market is expected to grow owing to factors such as growing prevalence of chronic diseases in pet animals and increasing adoption of pets for companionship. However, increasing pet care costs and extended pet lifespan are likely to restrain the growth of the market during the forecast period.

Zoetis Inc., IDEXX laboratories, Inc, Thermo Fisher Scientific Inc, Virbac, Randox Laboratories Ltd, idvet, IDEXX Laboratories, Inc, Heska Corporation, Fujifilm Corporation, and Skyla Corporation are among the leading companies operating in the companion animal diagnostics market.

Based on technology, the global companion animal diagnostics market is segmented into immunodiagnostics, clinical biochemistry, hematology, urinalysis, molecular diagnostics, and others. The immunodiagnostics segment is further sub-segmented into lateral flow assays, Elisa tests, allergen-specific immunodiagnostic tests, and immunoassay analyzers. Whereas the clinical biochemistry is sub-segmented into clinical chemistry analysis, glucose monitoring, and blood gas electrolyte analysis. The immunodiagnostics segment held a largest share of the market in 2019. However, the clinical biochemistry segment is estimated to register a higher CAGR during the forecast period owing to increasing adoption of clinical chemistry analysis, glucose monitoring, and blood gas electrolyte analysis products.

Click here to avail lucrative discounts on our latest reports. We offer student, enterprise, and special periodic discounts to our clientele. Please fill the inquiry form below to know more –

The report segments global companion animal diagnostics Market as follows:

By Technology

Immunodiagnostics

Lateral Flow Assays

Elisa Tests

Allergen-Specific Immunodiagnostic Tests Diagnostics

Immunoassay Analyzers

Clinical Biochemistry

Clinical Chemistry Analysis

Glucose Monitoring

Blood Gas Electrolyte Analysis

Hematology

Urinalysis

Molecular Diagnostics

Others

By Application

Bacteriology

Clinical Pathology

Virology

Parasitology

Others

By Animal Type

Dogs

Cats

Horses

Others

By End User

Diagnostic Laboratories

Veterinary Hospitals and Clinics

Research Institutes and Universities

By Geography

North America

US

Canada

Mexico

Europe

France

Germany

UK

Spain

Italy

Asia Pacific (APAC)

China

India

Japan

Australia

South Korea

Middle East and Africa (MEA)

Saudi Arabia

UAE

South Africa

South and Central America (SCAM)

Brazil

Argentina

Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods –

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

[mrfrblogresearch02]

Veterinary Laboratory Testing Market Size, Scope, Growth, Competitive Analysis 2027

Market Highlights

The global Veterinary Laboratory Testing Service Market is expected to grow at a CAGR of 10.1% during the forecast period.

Primary Drivers and Barriers

The mounting number of surgeries of pets, particularly in emerging nations facilitates the growth of the veterinary laboratory testing market. The key surgical procedures are dental, cataract, wound repair, hip dysplasia, and spay or neuter. Other factors include dramatic growth in the number of veterinary laboratory practitioners and the surge in technological advances in terms of new products and tools. The market growth is further bolstered by the escalation in health insurance for animals, burgeoning population of companion animals along with the soaring number of government initiatives to deal with the surge in zoonotic diseases.

Significant rise in periodontal issues among pets paired with the huge preference for high quality diagnostic testing options drives the global market growth. The rise in oral surgeries as well as periodontal surgeries has raised the demand for veterinary laboratory testing services.

Health issues such as obesity among pets and companion animals have surged considerably over the years, leading to heart diseases, diabetes, dental problems, and osteoarthritis. Majority of these conditions boost the need for veterinary laboratory testing services. Huge breakthroughs within the veterinary field benefits the global industry as well.

Regional Study

North America secures the lead in the global market for veterinary surgical instruments study guide, given the surging use of diagnostic tests as animal diseases continue to rise in the region. The lead has been taken by the United States, on account of the surging awareness level among the population about the latest laboratory-based diagnostics for their pets. The significant rise in technological advances in veterinary diagnostics is bound to raise the market demand in the following years.

Europe forms the second biggest market for veterinary laboratory testing services, in view of the surge in technical developments and the rising awareness among people. The burgeoning pool of animals like buffaloes, goats, and cow affected by different diseases would elevate the market position more in the years to come.

In Asian countries, the veterinary laboratory testing market is relatively new, but the progress rate in the years ahead is expected to be quite significant. Diseases such as rabies, which require detection via veterinary testing, are very commonly left undiagnosed in the region, leading to several deaths. As a result, countries like India have been increasingly adopting veterinary laboratory testing services and equipment to address the issue. Segmentation

The global veterinary laboratory testing market has been segmented into animal type, technology, product, and end user.

The market, on the basis of animal type, has been segmented into companion animal and livestock animal. The companion animal segment is further classified as dogs, cats, horses and others. The livestock animal segment is further classified as cattle, pigs, poultry and others.

The market, by technology, has been segmented into clinical biochemistry, immunodiagnostics, hematology, molecular diagnostics, urinalysis, and others.

The clinical biochemistry segment is further classified as clinical chemistry analysis, glucose monitoring, and blood gas & electrolyte analysis. The clinical chemistry analysis segment includes clinical chemistry reagent clips and cartridges and clinical chemistry analyzers. The glucose monitoring segment includes blood glucose strips, glucose monitors and urine glucose strips. The blood gas & electrolyte analysis segment includes blood gas and electrolyte reagent clips and cartridges and blood gas & electrolyte analyzers.

The immunodiagnostics segment is further classified as ELISA tests, lateral flow assays, allergen-specific immunodiagnostic tests, immunoassay analyzers, and others. The lateral flow assays segment includes lateral flow rapid tests, and lateral flow strip readers.

The hematology segment is further classified as hematology cartridges, and hematology analyzers.

The molecular diagnostics segment is further classified as polymerase chain reaction (PCR) tests, microarrays, and others.

The urinalysis segment is further classified as urinalysis clips & cartridges/panels, urine analyzers, and urine test strips.

The market, by product, has been segmented into consumables and instruments.

The market, by end user, has been segmented into veterinary hospitals & clinics, in-house testing, research institutes, diagnostic laboratories, and others. The veterinary hospitals & clinics segment held the largest segment of the market in 2017. This can be attributed to the increasing incidence of zoonotic diseases. On the other hand, the academic institutes segment is estimated to be the fastest growing segment.

Key Players

Some of the prominent players in the global veterinary laboratory testing market are Abaxis, Inc., BIOCHECK Inc., Biomérieux SA, Henry Schein, Inc., Heska Corporation, Idexx Laboratories, Idvet, Neogen Corporation, Pfizer, Qiagen N.V., Randox Laboratories, Ltd., Thermo Fisher Scientific, VCA Inc., Virbac, Zoetis, Inc. and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[jesse-pinkman123]

Blood Gas and Electrolyte Analyzers Market Research focuses on the key trends prevailing in the Global Blood Gas and Electrolyte Analyzers Industry sector. The existing Industry scenario has been studied and future projections with respect to the sector have also been investigated.